Sign in

AI Precision Trial Matching

AI Precision Trial Matching helps pharma and biotech sponsors automatically match patients to the most suitable clinical trials by analyzing clinical records, multi-omics data, and protocol criteria at scale. It optimizes adaptive trial design, recommends individualized treatment rules, and predicts trial success probability before and during enrollment. This accelerates recruitment, improves trial success rates, and reduces development time and cost for new therapies.

The Problem

“Match the right patients to the right trials faster while improving trial design and enrollment outcomes”

Organizations face these key challenges:

1

Eligibility criteria are unstructured, ambiguous, and frequently amended

2

Patient data are fragmented across EHR, lab, genomics, imaging, and registry systems

3

Manual chart review does not scale across large candidate populations

4

Institutions cannot share raw treatment-response data due to privacy and governance constraints

5

Adaptive confirmatory trial outputs are difficult to interpret consistently

6

Regulatory expectations for adaptive designs require traceable and repeatable reasoning

7

Missing or incomplete patient records cause false negatives and false positives in matching

8

Enrollment forecasting is weak for biomarker-driven and rare-disease studies

9

Clinical, biostatistics, and regulatory teams often work from disconnected tools and definitions

Impact When Solved

Reduce patient prescreening time from days to minutes per protocolIncrease enrollment velocity by prioritizing high-likelihood eligible patientsImprove screen-pass rates through more accurate eligibility interpretationSupport privacy-preserving multi-institution model training with federated learningDetect adaptive trial interpretation risks before submission or major decisionsPredict trial success probability using multimodal patient and protocol signalsLower protocol amendment and recruitment extension costsImprove individualized treatment rule recommendations for precision-medicine studies

The Shift

Before AI~85% Manual

Human Does

  • •Review trial protocols, prior studies, and patient records to assess eligibility and fit
  • •Manually compare fragmented clinical and biomarker evidence across candidate trials
  • •Decide trial design adjustments, cohort strategies, and treatment rules based on expert judgment
  • •Coordinate enrollment prioritization and portfolio decisions through cross-functional review

Automation

  • •No AI-driven matching or prediction used in the legacy workflow
  • •No automated synthesis of multi-omics, clinical, and protocol data
  • •No continuous prediction of enrollment fit or trial success probability
With AI~75% Automated

Human Does

  • •Approve final patient-to-trial matches and resolve ambiguous eligibility cases
  • •Review AI-generated trial success forecasts before design or portfolio decisions
  • •Set adaptive trial strategy, cohort changes, and individualized treatment policies

AI Handles

  • •Analyze clinical records, multi-omics data, and protocol criteria to rank patient-trial matches
  • •Pre-screen and triage patients across multiple trials using structured eligibility assessments
  • •Predict trial success probability and enrollment risk before and during recruitment
  • •Recommend adaptive design options and individualized treatment rules from large datasets

Operating Intelligence

How AI Precision Trial Matching runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence95%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6↺ Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in AI Precision Trial Matching implementations:

Individualized treatment rule frameworkOther
4 mentions
Convex smooth loss formulationOther
3 mentions
Distributed data-center training loopOther
3 mentions
Massive dataset supportOther
2 mentions
Summary statistics aggregationOther
2 mentions

Key Players

Companies actively working on AI Precision Trial Matching solutions:

Alternative distributed/federated healthcare ML methodsMeta-learning approaches that average local estimatesTraditional centralized integrative analysis

Real-World Use Cases

Federated precision-medicine modeling across multiple clinical data sources

Different clinics or studies can combine what they know to figure out which treatment works best for which kind of patient, without handing over the underlying patient files.

personalized treatment policy learningproposed method with simulation and case-study evidence; suitable as an emerging workflow rather than established standard practice.
10.0

AI-assisted interpretation checks for adaptive confirmatory trial results

An AI system reviews adaptive clinical trial plans and results to flag places where the study design or interpretation may make the final efficacy conclusion less reliable.

document intelligence + rule-based compliance reasoningproposed/regulatory-aligned use case; the source describes guidance principles rather than a deployed fda ai product.
10.0

Free access to this report